2-Hydroxypropyl-β-cyclodextrin extracts 2-phenylphenol from silicone tubing

International Journal of Pharmaceutics

Volumn 278, Issue 2, 2004, Pages 303-309

  Den Brok, Monique W J ^a   Van Der Schoot, Sabien C ^a   Nuijen, Bastiaan ^a   Hillebrand, Michel J X ^a   Beijnen, Jos H ^a,b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

2 Hydroxypropyl cyclodextrin; 2 Phenylphenol; Extraction; Formulation; Silicone tubing

Indexed keywords

2 HYDROXYBIPHENYL; 2 HYDROXYPROPYL BETA CYCLODEXTRIN; PLATINUM; SILICONE;

ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; EXTRACTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

BETA-CYCLODEXTRINS; BIPHENYL COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; ETHANOL; MASS SPECTROMETRY; PHASE TRANSITION; PRESERVATIVES, PHARMACEUTICAL; SILICONES; TECHNOLOGY, PHARMACEUTICAL;

EID: 2942583137     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.03.020     Document Type: Article

References (18)

1. Bartels M.J., McNett D.A., Timchalk C., Mendrala A.L., Christenson W.R., Sangha G.K., Brzak K.A., Shabrang S.N. Comparative metabolism of ortho-phenylphenol in mouse, rat and man. Xenobiotica. 28:1998;579-594
2. Brewster M.E., Simpkins J.W., Hora M.S., Stern W.C., Bodor N. The potential use of cyclodextrins in parenteral formulations. J. Parenter. Sci. Technol. 43:1989;231-240
3. European Pharmacopoeia, 2002. fourth ed. Council of Europe, Strasbourg.
4. Frömming, K.H., 1994. In: Szejtli, J. (Ed.), Cyclodextrins in Pharmacy. Kluwer Academic Publisher, Dordrecht.
5. Higuchi T., Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 7:1965;117-212
6. Jenke D.R. Evaluation of model solvent systems for assessing the accumulation of container extractables in drug formulations. Int. J. Pharm. 224:2001;51-60
7. JMPR. Joint FAO/WHO Meeting on Pesticide Residues, 1999. http://www.fao.org/WAICENT/FAOINFO/AGRICULT/AGP/AGPP/Pesticid/JMPR/Download/95/ anex1.PDF.
8. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85:1996;1017-1025
9. Loftsson T., Magnusdottir A., Masson M., Sigurjonsdottir J.F. Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 91:2002;2307-2316
10. Nuijen B., Bouma M., Manada C., Jimeno J.M., Lazaro L.L., Bult A., Beijnen J.H. Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices. Invest. New Drugs. 19:2001;273-281
11. Pearson M.M., Rogers P.D., Cleary J.D., Chapman S.W. Voriconazol: a new triazole antifungal agent. Ann. Pharmacother. 37:2003;420-432
12. Saenger W. Cyclodextrin inclusion compounds in research and industry. Angew. Chem. Int. Ed. Engl. 19:1980;344-362
13. Slain D., Rogers P.D., Cleary J.D., Chapman S.W. Intravenous intraconazol. Ann. Pharmacother. 35:2001;720-725
14. Stouten H. Toxicological profile for o-phenylphenol and its sodium salt. J. Appl. Toxicol. 18:1998;261-270
15. Szente L., Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv. Drug Deliv. Rev. 36:1999;17-28
16. Timchalk C., Selim S., Sangha G., Bartels M.J. The pharmacokinetics and metabolism of 14C/13C-labeled ortho-phenylphenol formulation following dermal application to human volunteers. Hum. Exp. Toxicol. 17:1998;411-417
17. US Pharmacopoeia XXIV, 2000. United States Pharmacopeial Convention Inc., Rockville, MD.
18. Zimmerman J.A., Ballard J.M., Wang H., Wu A., Gallagher K.A. Extraction of o-phenylphenol from silicone tubing by a sulfobutylether cyclodextrin formulation. Int. J. Pharm. 267:2003;113-120